Neutrolis
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Broadway Ste 14, Cambridge, Massachuse...Phone Number
(617) 863-3650Website
www.neutrolis.comRevenue
<$5 MillionIndustry
About Neutrolis
Neutrolis is a clinical-stage biotechnology company focused on developing first-in-class therapies that degrade neutrophil extracellular traps (NETs) to treat autoimmune and inflammatory diseases. The company aims to transform patient lives by addressing the root causes of these diseases without relying on immunosuppression. Utilizing its exDNASE platform, Neutrolis designs engineered molecules to target NETs, supported by robust biomarker technology. Their innovative approach seeks to improve treatment outcomes for patients suffering from conditions such as lupus, rheumatoid arthritis, and other NET-related disorders.Explore more
SIC Code 28,283NAICS Code 32,325Show moreNeutrolis Org Chart
Compare Similar Companies to Neutrolis
Compare insights from companies similar to Neutrolis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Neutrolis Tech Stack
A closer look at the technologies used by Neutrolis
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Neutrolis
Sign Up For FreeTo access detailed company insights
Neutrolis is a clinical-stage biotechnology company focused on developing first-in-class therapies that degrade neutrophil extracellular traps (NETs) to treat autoimmune and inflammatory diseases. The company aims to transform patient lives by addressing the root causes of these diseases without relying on immunosuppression. Utilizing its exDNASE p... Read More
